Concretely: 96.8% · VendorInvestigate · 98.2% · Medutest. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
reference-standard
Page 5 of 8 · 179 questions tagged reference-standard.
The case in front of me: semaglutide · a C4 column · cagrilintide. These are treated as interchangeable and I do not think they are. If both are acceptable I would…
Conditions: 98.4% · VendorInvestigate · 96.4% · Janoshik. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to…
I have started asking labs for "the system suitability data" and getting back either silence, a shrug, or a screenshot of six retention times. I clearly do not know…
Details up front: cagrilintide · a C8 column · cagrilintide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather…
Conditions: survodutide · a C4 column · survodutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
I have been reading certificates of analysis and I keep seeing the product name written three different ways: "semaglutide", "semaglutide sodium", and once…
The specifics, since they change the answer: liraglutide · a wide-pore C18 column · retatrutide. I am trying to choose between two options that are usually discussed…
Numbers first: a GLP-1 receptor agonist · a C8 column · mazdutide. I want to know what the trade-off actually is rather than which option is fashionable. I would…
For reference: 97.6% · PeptideMeter · 95.2% · Janoshik. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for…
Details up front: 95.2% · Janoshik · 97.1% · Medutest. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I can do the algebra. I am not confident about the conversion factors. If…
Details up front: a GLP-1 receptor agonist · a C8 column · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason.…
Setup, so nobody has to ask: orforglipron · a C18 column · survodutide. Both of these get recommended confidently by different people, which suggests neither is…
What I have: 97.6% · Janoshik · 98.4% · Medutest. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Numbers first: 97.6% · Janoshik · 98.8% · Janoshik. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
What I am working with: dulaglutide · a C18 column · survodutide. Both of these get recommended confidently by different people, which suggests neither is obviously…
What I am working with: 98.2% · Medutest · 96.8% · Janoshik. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can…
The case in front of me: 99.1% · VendorInvestigate · 98.4% · PeptideMeter. I would like the axes of comparison first and the recommendation second. I have tried the…
Setup, so nobody has to ask: retatrutide · a C18 column · liraglutide. Both of these get recommended confidently by different people, which suggests neither is…
Setup, so nobody has to ask: dulaglutide · a C18 column · retatrutide. I suspect the honest answer is that it depends, in which case I would like to know on what.…
Setup, so nobody has to ask: orforglipron · a C18 column · semaglutide. I suspect the honest answer is that it depends, in which case I would like to know on what.…
What I have: 99.4% · Janoshik · 97.1% · PeptideMeter. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
What I have: mazdutide · a C8 column · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…